CYP21A2 rs1057519068: Understanding This Genetic Variant
The rs1057519068 variant is located within the CYP21A2 gene, which plays a critical role in the production of essential steroid hormones. This variant is frequently documented in clinical databases and is studied in the context of adrenal health and hormone metabolism.
What each genotype means
Carrier of deletion variant
You carry one copy of the 12-nucleotide deletion and one copy of the standard sequence. While carriers are typically asymptomatic, this variant is linked to 21-hydroxylase deficiency. You should discuss these findings with a clinician to understand the implications for your health or family planning.
This heterozygous genotype is uncommon and is typically identified through targeted clinical screening for CYP21A2-related conditions.
Typical genetic profile
This genotype represents the standard sequence for this region of the CYP21A2 gene. It does not contain the 12-nucleotide deletion associated with 21-hydroxylase deficiency. This result is considered typical for this specific genetic location.
This is the most common genotype observed in the general population.
What is rs1057519068?
The variant rs1057519068 is a specific genetic change located on chromosome 6 within the CYP21A2 gene. In genomics, a variant like this represents a difference in the DNA sequence compared to the reference genome. Because the CYP21A2 gene is located in a complex region of the genome that includes a highly similar pseudogene, identifying and interpreting variants in this area requires specialized clinical testing. This specific variant is cataloged in major genetic databases, where it is monitored for its potential impact on biological function. Researchers track such variants to understand how they might influence the body's ability to process hormones, which are chemical messengers that regulate many vital bodily functions. While the presence of a variant is a standard part of human genetic diversity, its clinical significance depends on whether it alters the function of the protein the gene is responsible for creating.
The Role of the CYP21A2 Gene
The CYP21A2 gene provides the instructions for the body to produce an enzyme known as 21-hydroxylase. This enzyme is a member of the cytochrome P450 family and is essential for the adrenal glands to function correctly. Specifically, 21-hydroxylase is responsible for the final steps in the production of cortisol, a hormone that helps the body respond to stress, maintain blood pressure, and regulate metabolism. It is also involved in the production of aldosterone, which helps balance salt and water levels in the body. When the CYP21A2 gene is functioning normally, the body produces these hormones in the correct amounts. However, if the gene contains variants that significantly reduce or eliminate the activity of the 21-hydroxylase enzyme, it can lead to a condition known as 21-hydroxylase deficiency, which is the most common cause of congenital adrenal hyperplasia.
Research and Clinical Associations
Scientific research into the CYP21A2 gene is extensive because variants in this gene are the primary cause of congenital adrenal hyperplasia (CAH). Clinical databases often include this gene in panels used for carrier screening and diagnostic testing. While some variants in CYP21A2 are well-established as pathogenic, meaning they are known to cause disease, others are classified with varying levels of evidence. The rs1057519068 variant is noted in clinical datasets, and researchers continue to study its specific impact on enzyme activity. It is important to note that the presence of a variant does not automatically imply a health condition. Many factors, including the presence of other variants on the same or opposite chromosome, determine the overall effect on hormone production. Clinical interpretation of these variants is complex and typically involves evaluating the entire gene sequence rather than looking at a single SNP in isolation.
Understanding Your Results
If you have received information about the rs1057519068 variant, it is important to understand that this information is for educational purposes and does not constitute a medical diagnosis. Genetic testing results can be complex, especially for genes like CYP21A2 that are involved in critical metabolic pathways. You cannot use this information to make decisions about your health or medication without professional guidance. If you are concerned about your adrenal health or have a family history of hormone-related conditions, you should discuss these findings with a qualified healthcare provider, such as an endocrinologist or a genetic counselor. They can help interpret the results in the context of your personal health history and determine if further clinical testing is necessary. Always consult with your clinician or pharmacist before making any changes to your health management or medication regimen.
How common is this variant?
This variant is noted as common in clinical datasets, though specific frequency data across diverse global populations can vary significantly due to the complexity of the CYP21A2 locus.
Frequently asked questions
What is the CYP21A2 gene?
The CYP21A2 gene provides instructions for making the 21-hydroxylase enzyme. This enzyme is crucial for the production of cortisol and aldosterone in the adrenal glands.
Is rs1057519068 dangerous?
The clinical significance of any genetic variant depends on many factors, including your overall genetic profile. You should discuss this variant with a healthcare provider to understand what it means for your specific health situation.
Can I use this information to diagnose myself?
No. Genetic variants are only one piece of a complex health puzzle. Only a qualified medical professional can provide a diagnosis based on clinical symptoms, family history, and appropriate diagnostic testing.
Why is the CYP21A2 gene hard to test?
The CYP21A2 gene is located near a highly similar pseudogene called CYP21A1P. This similarity makes it difficult for standard genetic tests to distinguish between the two, often requiring specialized sequencing methods.
Sources & further reading
Educational information only, last refreshed 10/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1057519068?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CYP21A2
Classic 21-hydroxylase deficiency pathogenic variant (Val281Leu equivalent locus) associated with non-classic congenital adrenal hyperplasia, hyperandrogenism, and subfertility.
This variant is classified as pathogenic and is associated with 21-hydroxylase deficiency.
Pathogenic missense variant causing classical and non-classical congenital adrenal hyperplasia with virilization and subfertility.
Well-characterized mutation in CYP21A2 causing 21-hydroxylase deficiency, leading to ambiguous genitalia in females.
This variant is associated with non-classical congenital adrenal hyperplasia, a condition affecting cortisol production.
Pathogenic variant associated with non-classic congenital adrenal hyperplasia presenting with hyperandrogenism, oligomenorrhea, and subfertility.